Sequoia Financial Advisors LLC Has $927,000 Position in Humana Inc. $HUM

Sequoia Financial Advisors LLC lifted its position in shares of Humana Inc. (NYSE:HUM) by 112.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,790 shares of the insurance provider’s stock after purchasing an additional 2,005 shares during the period. Sequoia Financial Advisors LLC’s holdings in Humana were worth $927,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Janney Montgomery Scott LLC bought a new stake in Humana in the 1st quarter valued at about $1,309,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Humana by 16.2% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,136,538 shares of the insurance provider’s stock worth $300,728,000 after acquiring an additional 158,528 shares during the period. Focus Partners Wealth increased its position in Humana by 104.2% during the 1st quarter. Focus Partners Wealth now owns 6,429 shares of the insurance provider’s stock worth $1,701,000 after purchasing an additional 3,281 shares in the last quarter. Envestnet Asset Management Inc. increased its position in Humana by 2.4% during the 1st quarter. Envestnet Asset Management Inc. now owns 125,684 shares of the insurance provider’s stock worth $33,256,000 after purchasing an additional 2,950 shares in the last quarter. Finally, Circle Wealth Management LLC acquired a new position in Humana during the 1st quarter worth approximately $425,000. Institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on HUM shares. Wolfe Research upped their price objective on shares of Humana from $283.00 to $313.00 and gave the stock an “outperform” rating in a research report on Monday, October 6th. Robert W. Baird decreased their price target on shares of Humana from $300.00 to $297.00 and set a “neutral” rating for the company in a research report on Friday, July 25th. Bank of America lifted their price target on shares of Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a report on Friday, October 10th. Truist Financial set a $300.00 price target on shares of Humana in a report on Tuesday. Finally, Guggenheim reiterated a “buy” rating on shares of Humana in a report on Friday, October 3rd. Eight equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $297.58.

Humana Trading Up 2.9%

HUM opened at $275.00 on Friday. The stock has a market cap of $33.07 billion, a PE ratio of 21.11, a price-to-earnings-growth ratio of 1.56 and a beta of 0.42. Humana Inc. has a twelve month low of $206.87 and a twelve month high of $315.35. The company has a fifty day moving average of $280.54 and a 200-day moving average of $258.23. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). The company had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm’s revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the company earned $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. On average, sell-side analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date of this dividend is Friday, September 26th. Humana’s dividend payout ratio (DPR) is 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.